Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
2024-03-20 Sale | 2024-03-22 5:00 pm | AbbVie Inc. | ABBV | Donoghoe Nicholas EVP, CHIEF BUS/STRAT OFFICER | 21,082 | $176.3 | $3,716,757 | 55,903 (Direct) | View |
2023-12-26 Sale | 2023-12-28 5:00 pm | AbbVie Inc. | ABBV | Donoghoe Nicholas EVP, CHIEF BUS/STRAT OFFICER | 2,912 | $154.72 | $450,545 | 55,903 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
2024-02-28 Tax Withholding | 2024-03-01 5:50 pm | N/A N/A | AbbVie Inc. | ABBV | Donoghoe Nicholas EVP, CHIEF BUS/STRAT OFFICER | 16,771 | $178.99 | 76,985 (Direct) | View |
2024-02-15 Option Award | 2024-02-20 5:17 pm | 2025-02-15 2034-02-14 | AbbVie Inc. | ABBV | Donoghoe Nicholas EVP, CHIEF BUS/STRAT OFFICER | 59,286 | $0 | 115,189 (Direct) | View |
Ownership | 2023-07-10 5:04 pm | N/A N/A | AbbVie Inc. | ABBV | Donoghoe Nicholas EVP, Chief Bus/Strat Officer | 0 | $0 | 232,359 (Direct) | View |
2020-02-28 Tax Withholding | 2020-03-03 4:51 pm | N/A N/A | AbbVie Inc. | ABBV | Donoghoe Nicholas SVP, Enterprise Innovation | 2,355 | $85.42 | 15,149 (Direct) | View |
2020-02-20 Option Award | 2020-02-24 6:04 pm | 2021-02-20 2030-02-19 | AbbVie Inc. | ABBV | Donoghoe Nicholas SVP, Enterprise Innovation | 77,329 | $0 | 89,517 (Direct) | View |
2020-01-02 Tax Withholding | 2020-01-06 4:28 pm | N/A N/A | AbbVie Inc. | ABBV | Donoghoe Nicholas SVP, Enterprise Innovation | 902 | $88.54 | 12,188 (Direct) | View |